of 46 /46
DIABETES MELLITUS ISSUES IN THE LONG TERM CARE SETTING AND ALLIED VENUES

Dr. Escher

Embed Size (px)

Text of Dr. Escher

  • 1.DIABETES MELLITUS ISSUES IN THELONG TERM CARE SETTING AND ALLIED VENUES

2. DIABETES MELLITUS

  • Focus:diabetes in the Medicare population

3. DIABETES MELLITUS

  • Definition: a metabolic disorder in which
  • there is deficiency of insulin production or
  • resistance of organs to the effect of insulin

4. DIABETES MELLITUS

  • Diabetes is a disorder of metabolism--the way our bodies use digested food for growth and energy.
  • Most of the food we eat is broken down into glucose, the form of sugar in the blood.
  • Glucose is the main source of fuel for the body.

5. DIABETES MELLITUS

  • After digestion, glucose passes into the bloodstream, where it is used by cells for growth and energy.
  • For glucose to get into cells, insulin must be present.
  • Insulin is a hormone produced by the pancreas, a large gland behind the stomach.

6. DIABETES MELLITUS

  • NORMAL: When non-diabetic people eat, the pancreas automatically produces the right amount of insulin to move glucose from blood into our cells.

7. DIABETES MELLITUS

  • DIABETES: In people with diabetes, when they eat,the pancreas either produces little or no insulin, or the cells do not respond appropriately to the insulin that is produced (or both)=> glucose builds up in the blood, overflows into the urine, and passes out of the body in urine => body loses its main source of fuel even though blood contains large amounts of glucose.

8. DIABETES MELLITUS (DM)

  • TYPES OF DIABETES
        • Type I
        • Type II
        • MODY (Maturity Onset Diabetes of Youth
        • Gestational

9. DM TYPE I

  • Auto-immune disease
  • Constitutes 5-10% of DM diagnosed in the USA
  • Mostly appears in children and young adults
  • Develops as a result of auto-immune destruction of beta-cells in the pancreas
  • Presents with polyuria, thirst, weight loss, marked fatigue
  • Can be complicated by coma with ketoacidosis

10. DM TYPE II

  • Most common form of diabetes
  • Involves about 90-95% of people with DM
  • Associated with:
    • older age
    • obesity
    • family history of DM
    • prior history of gestational diabetes
    • physical inactivity
    • ethnicity

11. DM TYPE II

  • Patient with type II DM usually makes enough insulin but the body cannot use it effectively =>insulin resistance
  • Graduallyinsulin productiondecreases over the following years
  • Symptoms are similar to type I but develop more gradually

12. DM TYPE II

  • Symptoms of type II DM include:
    • Fatigue
    • Nausea
    • Frequent urination/polyuria
    • Thirst
    • Unusual weight loss
    • Blurred vision
    • Frequent infections
    • Slow healing of wounds or sores
    • Sometimes no specific symptoms

13. GESTATIONAL DIABETES

  • Develops only during pregnancy
  • More common in:
    • African Americans
    • American Indians
    • Hispanic Americans
    • women with a family history of diabetes
  • Women with a history of gestational diabetes have a 20-50% chance of getting type II DM within 5-10 years

14. Diabetes Mellitus: Diagnosis

  • Fasting plasma glucose =preferred test : Positive test is glycemia of 126mg/dL or higher after fasting at least 8 hours
  • Random plasma glucose of 200mg/dL or higher along with symptoms of diabetes
  • Oral glucose tolerance test (OGTT) plasma glucose of 200mg/dL or higher done 2 hours after ingestion of 75 grams of glucose in water
  • MKSAP13 Endocrinology and Metabolism. American College of Physicians 2004.

15. Diabetes Mellitus

  • Hemoglobin A1c measurement isnotrecommended currently for diagnosis of diabetes.
  • HbA1c is used as a marker to monitor glycemia control in patients over time
  • MKSAP13 Endocrinology and Metabolism. American College of Physicians 2004.

16. Pre-Diabetes

  • Pre-diabetes refers to a state between normal and diabetes= fasting plasma glucose 100-125mg/dL (higher than normal but not high enough for diagnosis of diabetes) Affects about 41 million people in USA (previously referred to as either impaired fasting glucose or impaired glucose tolerance)
  • http://diabetes.niddk.nih.gov/dm/pubs/overview/index.htm#types
  • MKSAP13 Endocrinology and Metabolism. American College of Physicians 2004.

17. Type II Diabetes

  • Diagnostic testing - when to do it:
  • People45 years old=> if normal then every 3 years
  • MKSAP13 Endocrinology and Metabolism. American College of Physicians 2004.

18. Type II Diabetes: diagnostic testing

  • Youngerthan 45 yo or more often than every 3 years if:
  • overweight
  • first degree relative with diabetes
  • member of high risk ethnic group (Afro-American, Hispanic American, Native American, Asian American, Pacific Islander)
  • delivered a baby9 lbs.
  • gestational diabetes
  • hypertensive (BP140/90mmHg)
  • High Density Lipoprotein cholesterol 35mg/dl or less
  • TriGlyceride level 250mg/dl or more
  • pre-diabetes
  • MKSAP13 Endocrinology and Metabolism. American College of Physicians 2004.

19. DM type II: Management

  • Basics:
  • healthy eating
  • physical activity
  • blood glucose testing
  • Pharmaceuticals:
  • oral medication(s)
  • insulin(s)
  • both oral medicines and insulin

20. DM: insulin variations

  • Daily insulin requirements are influenced by:
  • diet
  • exercise
  • stress

21. Diabetes Management: Stress

  • Stress influences response to insulin
  • Stress =>increased cortisol
  • increased catecholamines
  • increased growth hormone
  • => these hormones all lead to increased insulin resistance (thus, hyperglycemia)

22. Control of Diabetes

  • Control of Diabetes includes:
  • glycemia control (FBS < 126mg/dL; HbA1c pharmacotherapy (medications)

24. Insulins

  • Type hours to onset time to peak time effective
  • Fast acting:
  • Lispro 7%despitelife style modification and 2 oral medications
  • May be postponed in borderline cases where HbA1c is < 8.5% pending addition of a 3rd oral agent; otherwise =>
  • Addition of bedtime dose of basal insulin therapy (glargine) to sulfonylureas +/- metformin (not thiazolidinediones because of risk of CHF from fluid retention)

29. The Metabolic Syndrome

  • Hypertension
  • Visceral (central) obesity
  • Hypertriglyceridemia
  • Low HDL cholesterol
  • Insulin resistance or glucose intolerance
  • Prothrombotic state (high fibrinogen or plasminogen activator inhibitor [-1] in blood)
  • Proinflammatory state (high C-reactive protein in blood)
  • http://www.americanheart.org/presenter.jhtml?identifier=4756

30. Acute Complications of type II DM

  • Hyperglycemic hyperosmolar state:
  • common in elderly
  • triggered by underlying disorder(s)
  • risk increased in elderly due to decreased thirst reflex
  • often complicated by delirium

31. Acute Complications of type II DM

  • Hyperglycemic hyperosmolar state:
  • serum osmolarity > 320 mosm/L
  • plasma glucose > 600mg/dL
  • dehydration
  • no ketoacidosis
  • underlying disorder(s)

32. Hyperosmolar State

  • Therapy:
  • rehydration with hypotonic solution
  • insulin infusion (initially)
  • watch for signs of fluid overload/CHF
  • monitor potassium
  • treat underlying cause (eg UTI, cellulitis)

33. Hypoglycemia

  • Hypoglycemia = plasma glycemia < 50mg/dL with or without symptoms
  • More common in type I DM and patients with significant renal or liver disease
  • Another reason for glucose monitoring
  • Treated with po sugar (e.g. fruit juice or glucose tablets)
  • or IV dextrose 50% in water orIV glucagon or both

34. Complications of DM

  • Chronic complications of diabetes mellitus include:
  • Macrovascular
  • Microvascular
  • Neuropathic

35. Complications of DM

  • Macrovascular
  • atherosclerosis/cardiovascular disease
  • peripheral vascular disease

36. Complications of DM

  • Microvascular diabetic retinopathy : due to ischemia of retna; provokes neovascularization with vessels more fragile => leaking => scarring & fibrosis
  • diabetic nephropathy :common cause of ESRD;
  • prevention via control of blood pressure and glycemia; earliest signs urine albumin 30mg/day or 20 g/min; appears to benefit from ACE-Is and ARBs too

37. Complications of DM

  • Diabetic Neuropathy
  • peripheral sensory neuropathy
  • cardiovascular autonomic neuropathy
  • gastrointestinal autonomic neuropathy
  • erectile dysfunction
  • mononeuropathy
  • diabetic foot

38. Complications of DM

  • Peripheral sensory neuropathy
  • variable presentation
  • dysesthesia
  • tingling
  • pain
  • loss of pain sensation (risk of injury)

39. Complications of DM

  • Cardiovascular Autonomic Neuropathy
  • orthostatic hypotension
  • lack of normal variation in heart rate with breathing, tachycardia

40. Complications of DM

  • Gastrointestinal Autonomic Neuropathy
  • gastroparesis: nausea, bloating, vomiting (tx metoclopramide)
  • diarrhea: often nocturnal

41. Complications of DM

  • Erectile dysfunction:
  • autonomic neuropathy
  • absent nocturnal and morning erections
  • more common than diagnosed

42. Complications of DM

  • Mononeuropathy
  • acute local pain
  • distribution of a nerve
  • may recede if treated early with improved glucose control (glucotoxicity)

43. Complications of DM

  • Diabetic Foot
  • sensory deficit (skin, bone, ligament)
  • fungal infection
  • wounds
  • pulses (PVD)
  • slow healing
  • ulcers

44. Type II DM: Goals

  • Prevention of pre-diabetes
  • Prevention of change from pre-diabetes to diabetes
  • Diagnosis through screening
  • Early management/therapy
  • Prevention of complications

45. Type II DM: Goals

  • Screening via fasting glycemia and history
  • Life-style history and modification
  • Physical activity
  • Diet
  • Treatment of glycemia, lipids, hypercoagulable state, blood pressure
  • Management of complications

46.